$32.32
1.354.36%
Benzinga
Benzinga
Benzinga
金曜日, 10 16
Benzinga
© 2026 Benzinga | All Rights Reserved
Agios Pharmaceuticals (AGIO) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-1.71 | $-1.79 | $-1.96 | $-1.92 |
| Actual | $-1.69 | $-1.69 | $-1.86 | $-1.78 |
| Surprise | +1.17% | +5.59% | +5.10% | +7.29% |
| Revenue | ||||
| Estimate | $25.6M | $13.8M | $11.4M | $10.4M |
| Actual | $44.7M | $20.7M | $20.0M | $12.9M |
| Surprise | +74.5% | +50.0% | +75.9% | +23.8% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-1.24 | $-1.16 | $-1.20 | $-1.21 |
| Revenue | ||||
| Consensus | $50.3M | $58.3M | — | — |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q2 | Jul 30, 2026 | $-1.69 | $-1.71 | 1.17 % |
| Q1 | Apr 29, 2026 | $-1.69 | $-1.79 | 5.59 % |
| Q4 | Feb 12, 2026 | $-1.86 | $-1.96 | 5.10 % |
| Q3 | Oct 30, 2025 | $-1.78 | $-1.92 | 7.29 % |
| 会計四半期 | 報告日 | 実際の収益 | 推定収益 | 驚き ％ |
|---|---|---|---|---|
| Q2 | Jul 30, 2026 | $44.75M | $25.64M | 74.5 % |
| Q1 | Apr 29, 2026 | $20.75M | $13.83M | 50.0 % |
| Q4 | Feb 12, 2026 | $19.97M | $11.35M | 75.9 % |
| Q3 | Oct 30, 2025 | $12.88M | $10.40M | 23.8 % |